Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guiyang Qianfeng Biological Products is a prominent Chinese biopharmaceutical company specializing in the development and manufacture of plasma-derived therapeutics. Based in Guiyang, Guizhou Province, the company operates as a key subsidiary of Beijing Tiantan Biological Products, which is part of the state-owned Sinopharm group. Its core product portfolio includes human albumin, intravenous immunoglobulins, and specialized hyperimmune globulins for hepatitis B, rabies, and tetanus. The company maintains a network of plasma collection stations and large-scale fractionation facilities that adhere to national Good Manufacturing Practice (GMP) standards. Guiyang Qianfeng plays a vital role in the Chinese healthcare system by providing essential blood products used in emergency medicine, immunology, and surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guiyang Qianfeng Biological Products.